bpc 157 water UPB BPC-157 5MG BPC-157 Research Peptide | Specs

Important information about your prescription program

However, it never received FDA approval because the results, while positive, weren't dramatic enough to meet regulatory thresholds for an obesity drug

Side Effects & Safety Excellent safety profile 40 mg daily was well-tolerated for 12+ weeks in TAZPOWER No dose-limiting toxicity up to 0.25 mg/kg IV in Phase I Occasional mild injection site irritation at community doses Rare initial energy fluctuations first few days only No significant adverse events in any clinical trial Community sources describe 500 mcg daily as generally well-tolerated , consistent with the absence of adverse events reported in clinical trials at significantly higher doses mg to Units Conversion On a standard 100-unit insulin syringe, each "unit" equals 0.01 mL (so 100 units = 1 mL)

Your BHRC physician will provide specific dosing instructions based on your individual protocol